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We investigated electrophysiological properties of human induced-pluripotent-stem-cell-derived and
embryonic-stem-cell-derived cardiomyocytes, and analyzed action potential parameters by plotting their
frequency distributions. In the both cell lines, the distribution analysis revealed that histograms of
maximum upstroke velocity showed two subpopulations with similar intersection values. Sub-
populations with faster maximum upstroke velocity showed signiﬁcant prolongation of action poten-
tial durations by application of E-4031, whereas others did not, which may be partly due to shallower
maximum diastolic potentials. We described electrophysiological and pharmacological properties of
stem-cell-derived cardiomyocytes in the respective sub-populations, which provides a way to charac-
terize diverse electrical properties of stem-cell-derived cardiomyocytes systematically.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Considerable attention has been paid to the potential of hu-
man induced pluripotent stem cells (hiPSC) as an unlimited cell
source for in vitro screening assays, because the production of
hiPSC production possess less legal and ethical issues than that
of human embryonic stem cells (hESC) (1e3). As a conventional
assay for toxicological/pharmacological evaluations, ﬁeld poten-
tials measurement from multi-cellular preparations with micro-
electrode array (MEA) platform (4,5) is utilized to reduce cell-to-
cell variation of action potential (AP) dynamics (2,6,7), some
reports revealed that considerable variation exists in commer-
cially available cell-lines (8,9). Indeed, mixture of non-myocyte
or different types changes excitability of multicellular prepara-
tions (10). This indicates necessity of precise information on cell-
to-cell variation to understand mechanistic insights on results
with conventional MEA assay. However, in previous single-cell-ku, Tokyo, 113-8510, Japan.
ologies, RIKEN Center of Life
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rmacological Society.
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d/4.0/).analysis, cells were classiﬁed into arbitrary three types (i.e.
nodal, atrial and ventricular) without applying distribution
analysis (6,7,11), mainly because of small cell numbers. Thus, we
collected signiﬁcant numbers of action potential data from
patch-clamped hSC-CMs, and analyzed frequency distribution of
AP parameters to characterize the cell properties in respective
sub-populations.
Cell cultures and isolation of the both cardiomyocytes were
performed according to the company's protocols. In brief, frozen
hiPSC-CMs (iCell cardiomyocytes, lot#1131800, #1791676,
#1341341, iPS PORTAL, Kyoto, Japan) were thawed, and embryoid
bodies of hESC-CMs (SA002, Cellartis AB, Goteb€org, Sweden) were
shipped. Then, cells were isolated by trypsinization (0.25% trypsin-
EDTA) from cell sheets or embryoid bodies respectively, and plated
onto 0.5% gelatin/10 mg/ml laminin-coated plasma-etched glass
bottom dishes, and used within two weeks. Isolated hiPSC-CMs
were maintained in the CDI maintenance medium at 37 C and at
7% CO2. Isolated hES-derived cardiomyocytes were maintained in
DMEM supplemented with 5 mM GlutaMax™, 20% FBS, 1% Pen/
Strep, 1% non-essential amino acids, 0.2% 2-mercaptoethanol, and
were kept at 37 C and 5% CO2. E-4031 (40-[[1-[2-(6-methyl-2-
pyridyl)ethyl]-4-piperidinyl]carboxyl]methanesulfonanilide dihy-
drochloride dehydrate, Eisai Co., Tokyo) was kept as 10 mM stock innese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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tained from standard sources.
Action potentials were recorded at 36 ± 1 C with the perfo-
rated patch conﬁguration as described previously (12). External
solution contained (in mM): NaCl (135), NaH2PO4 (0.33), KCl (5.4),
CaCl2 (1.8), MgCl2 (0.53), glucose (5.5), HEPES (5), pH 7.4. To
achieve patch perforation (<20 MU; series resistances), ampho-
tericin B (0.3 mg/ml) was added to the internal solution composed
of (in mM): potassium-aspartate (110), KCl (30), CaCl2 (1), aden-
osine-50-triphosphate magnesium salt (5), creatine phosphate
disodium salt (5), HEPES (5), EGTA (11), pH 7.25. We adopted the
AP data only when more than 35 stable AP traces were recorded.
Data were acquired and analyzed using pClamp10 software
(Molecular Devices, Sunnyvale, CA, USA). In quiescent cells, 2-ms
duration current pulses (120% of the threshold intensity) were
applied to elicit APs. All values are presented as mean ± S.E.M.
Statistical signiﬁcance was assessed with Student's t-test for
simple comparisons and non-parametric KolmogoroveSmirnov
test for frequency distributions by using OriginPro 8 software0 20 40 60 80 100
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Fig. 1. Distributions of electrophysiological parameters in hiPSC- and hESC-derived cardiom
single or multiple Gaussian distributions. Multiple Gaussian functions were applied when co
fraction (i.e. peak) in multiple ﬁtting was calculated from ratio of each peak area. (A) Freque
hiPSC-CMs (white bars, upper panels) and 54 hESC-CMs (gray bars, lower panels). The distri
(30.2%) of Gaussian distribution (intersection 0.82 Hz, R2 ¼ 0.88). (B) Frequency distribution
bars, lower panels). Frequency peaks (% fraction for multiple distributions) of dV/dtmax a
R2 ¼ 0.927), and hESC-CMs; 3.3 V/s (50.8%) and 7.4 V/s (49.2%) on hESC-CMs (intersection 5.
were shown in red dotted lines. (C) Scatterplot representation of upstroke velocity (dV/dtma
(black dots, right panel). Representative AP waveforms at precincts are shown in insets.(Origin Lab Co, Northampton MA, USA). Differences at P < 0.05
were considered to be signiﬁcant.
In Fig. 1 and Table 1, APs recorded from 54 hiPSC-CMs and 80
hESC-CMs were summarized. Although the beating rate (BR) in
hiPSC-CMs was signiﬁcantly slower than that in hESC-CMs with
comparing two averages (Table 1), it is difﬁcult to conclude that
these cells have different phenotypes. Because the distribution
analysis revealed that hiPS-CM in itself would have at least more
than two phenotypes, which is consistent with signiﬁcantly larger
variations of beat-to-beat times shown as bigger coefﬁcient of
variation (CV) in hiPS-CM (Fig. 1A and Table 1).
In terms of AP parameters, there was no statistical difference
in average values of AP parameters (Table 1): AP amplitude
(APA), AP duration at 50% and 70% of repolarization (APD50,
APD70), maximum upstroke velocity (dV/dtmax), APD ratio during
phase 2 (APD20e40/APD50e70); an indicative of AP plateau, and
APD ratio (APD90/APD50); an indicative of phase 4 depolarization,
except of slight but signiﬁcant differences in mean values of
maximum diastolic potential (MDP) (Table 1). Relatively large1000 1500 0 10 20 30
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yocytes (CMs). Histograms for AP (A) and beating rate (B) parameters were ﬁtted with
efﬁcient of determination (R2) on single Gaussian ﬁtting fell below 0.81. Rate (%) of each
ncy distribution of BR and its coefﬁcient of variation (CV) in spontaneously AP ﬁring 39
bution on the BR of hiPSC-CMs showed two major peaks at 0.38 Hz (69.8%) and 0.88 Hz
of AP parameters in 54 hiPSC-CMs (white bars, upper panels) and 80 hESC-CMs (gray
re as follows: hiPSC-CMs; 2.6 V/s (50.8%) and 6.4 V/s (49.2%) (intersection 4.11 V/s,
25 V/s, R2 ¼ 0.941), respectively. The intersections of bimodal distributions for dV/dtmax
x) against APD20e40/APD50e70 ratio in hiPSC-CMs (white dots, left panel) and hESC-CMs
Table 1
Summary of action potential parameters obtained from individual hiPS-cardiomyocytes and hES-cardiomyocytes. Action potential (AP) parameters (mean ± S.E.M.) were
determined by averaging data from three consecutive APs at steady state. * P < 0.05, ** P < 0.01, *** P < 0.001 unpaired Student's t-test.
Spontaneous and paced AP hiPS-CMs (n ¼ 54) hES-CMs (n ¼ 80)
APA (mV) 79.4 ± 2.9 81.8 ± 2.5
MDP (mV) 43.3 ± 1.7 48.9 ± 1.5*
APD50 (ms) 309.4 ± 29.5 273.7 ± 28.7
APD70 (ms) 380.0 ± 32.2 339.4 ± 30.1
APD20e40/APD50e70 1.4 ± 0.1 1.5 ± 0.1
APD90/APD50 2.8 ± 0.3 2.9 ± 0.2
dV/dtmax 27.3 ± 5.3 18.0 ± 2.6
Spontaneous AP only hiPS-CMs (n ¼ 39; 72% out of total cell numbers) hES-CMs (n ¼ 58; 73% out of total cell numbers)
Beating rate (Hz) 0.6 ± 0.1 1.0 ± 0.1**
CV of beating rate (%) 28.9 ± 2.8 15.9 ± 1.9***
APA: action potential amplitude, CM: cardiomyocytes, MDP: maximum diastolic potential, APD50 and APD70: action potential duration at 50 and 70% of repolarization,
dV/dtmax: maximum upstroke velocity, APD20eAPD40/APD50eAPD70: APD ratio which indicates “plateau” during phase 2, APD90/APD50: APD ratio which indicates the
presence of phase 4 depolarization, CV: coefﬁcient of variation indicating SD/mean.
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distributed in a wide range. We therefore plotted the data with
frequency distribution. In Fig. 1A and B, the histogram for most of
parameters was ﬁtted to single Gaussian distributions with more
than 0.81 of R2 values (Fig. 1B). Exceptionally, histograms on
APD50 and APD70 of hiPSC-CMs were widely distributed, and R2
values of the ﬁtting could not be less than 0.81 using multiple
Gaussian ﬁtting, or not be converged to the single result. Despite
differences on each APD parameter, mean values for ratios of
APD (APD20e40/APD50e70 and APD90/APD50) were similar and
were ﬁtted with single Gaussian distribution in both cell-lines
(Table 1 and Fig. 1B), indicating indistinguishable at repolariza-
tion processes. On the other hand, the histograms of dV/dtmax,
upstroke velocity, showed bimodal distributions composed of a
slow and a fast fraction. In these cases, intersections of two
Gaussian curves in hiPSC-CMS and hESC-CMs were 4.11 (V/s) and
5.25 (V/s), respectively. Although these subtle differences existed
in the distribution pattern, there was no statistical signiﬁcance
for differences of AP parameters between hiPSC-CMs and hESC-
CMs as previously described by others (13). Fig. 1C shows the
relationship between waveform of action potential and two AP
parameters. These parameters (APD20e40/APD50e70 and dV/dtmax)
are well-known indices reﬂecting the duration of depolarization
or plateau phase, so it is usable to distinguish the cell types, i.e.,
between nodal and atrial/ventricular types, or between atrial and
ventricular types. When APD20e40/APD50e70 was plotted against
dV/dtmax in Fig. 1C, arbitrary “ventricular-like” cells were seen
only if dV/dtmax was larger than 4.11 (V/s) on hiPSC-CMs and
5.25 (V/s) in hESC-CMs, respectively. Additional distribution
analysis with faster dV/dtmax in Supplementary Figure 1 did not
provide numerical criteria to segregate “atrial-like” and “ven-
tricular-like”.
In Fig. 2, the effects of a standard hERG blocker, E-4031, on AP
traces were investigated both in hiPSC-CMs and hESC-CMs. Ac-
cording to previous reports on cardiac toxicological assessment
using hSC-CMs, it has been noticed that “ventricular-like” cells
are more responsive to QT-prolonging drugs (6), but no study has
provided any numerical criteria of AP parameters to categorize
“ventricular-like” cells. We therefore asked whether our distri-
bution analysis allows segregating cell populations which are
responsive to drugs. To test this, we employed the intersection
dV/dtmax values (4.11 V/s for hiPS-CMs and 5.25 V/s for hES-CMs)
(Fig. 1B). Then, the effect of E-4031 on APD was investigated in
two subpopulations with slow or fast dV/dtmax (Fig. 2D). Without
considering the subpopulations, we found a wide variety of re-
sponses to E4031 application at each concentration tested,resulting in neither evident effect on APD70 nor occurrence of
EAD (Fig. 2AeC). With considering the subpopulations in Fig. 2D
and F, in the case of hiPSC-CMs with fast upstroke velocity (7
cells), E-4031 at 10 nM tended to prolong APD70, although it was
not statistically signiﬁcant (P ¼ 0.08). In these cells, high con-
centration of E-4031 did not alter APD70, which is due to dramatic
AP alternation as shown in Fig. 2B right. In contrast, in the case of
hiPSC-CMs with slow upstroke velocity (3 cells), E-4031 either at
10 nM and 100 nM did not alter APD70 (2 out of 3 cells) or
arrested (1 out of 3 cells). Similar results were obtained in hESC-
CMs. With fast upstroke velocity (9 cells), E-4031 at 10 nM tended
to prolong APD70 but not signiﬁcantly (P ¼ 0.05), and an appli-
cation of 100 nM E-4031 (4 out of 9 cells) diminished the ten-
dency. With slow upstroke velocity (3 cells), the E-4031
application did not alter APD70 and arrested at 100 nM in one out
of 3 cells. E4031 also depolarized MDP in some cells (Fig. 2A). But
there was no signiﬁcant effect on MDP, when all the data were
analyzed (Fig. 2E). In the hiPSC-CMs, the subpopulation with slow
upstroke velocity had shallower MDP than that with fast upstroke
velocity. But effects of E-4031 on MDP were unclear (Fig. 2F). In
hESC-CMs, the difference of MDP without drugs between slow or
fast upstroke velocities was not clear as shown in hiPSC-
cardiomyocytes (Fig. 2F).
In this study, we evaluated basic electrophysiological character-
istics of hiPSC-CMs, and theywere comparedwith those ofhESC-CMs
by analyzing frequency distribution. The major ﬁndings of this study
are as follows: (1) Average values of the AP parameters in hiPSC-CMs
and hESC-CMs were statistically undistinguishable from each other
with the exception of MDP and beating rate. (2) Our distribution
analysis of AP parameters from single cell data presented away to set
numerical criteria to segregate respective subpopulations. (3) It is
possible that the subpopulation with fast upstroke velocity exhibit
APD prolongation by an application of E-4031.
If respective subpopulations of hSC-CMs exhibit various phar-
macological responses, it may be worth knowing respective cell
properties to understand molecular mechanisms for developing
speciﬁc cell types or predicting multicellular responses by system
biological approaches. Although long APD90 has been used as an
arbitrary criterion for drug sensitivity in a particular cell source (9),
it must be difﬁcult to apply this to others (8,13). Our distribution
analysis proposed a possible way to set numerical criteria for drug
sensitivity, although more cell numbers or higher purity or greater
maturation may be necessary in the future. In conclusion, our dis-
tribution analysis could add useful information on electrophysio-
logical properties of hiPSC-CMs for in vitro pharmacological
screening assays.
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Fig. 2. Effects of E-4031 on APD70 in hiPSC-CMs and hESC-CMs. (A) Representative AP waveforms in hiPSC-CM 1 (B, left) without (control) or with E-4031 (10, 100 nM and 1 mM). (B)
Individual variability in the response to E-4031. Overlay of expanded traces marked in (A) with open black dot (control), open red dot (10 nM) and closed red dot (100 nM) (left).
hiPSC-CM2 showing decreasing effect on APD70 at 100 nM E-4031 (right). (C) Dose-response bar graphs of E-4031 effect on APD70. hESC-CMs white bars and hESC-CMs gray bars.
(D) Effect of E4031 effect on the subpopulations segregated by cut-off points of dV/dtmax (4.11 V/s for hiPS-CM, and 5.25 V/s for hES-CMs) resulting from Fig. 1A. Cells with faster
upstroke (>4.11 V/s for hiPS-CMs and >5.25 V/s for hES-CMs) presented enhanced prolongation of APD70. (E) Bar graph of the depolarizing effect elicited by E-4031. Each bar
indicates mean ± SEM. n: indicated by numbers in brackets. No signiﬁcant differences were found. (F) Dose-response curves of E4031 effect on MDP of the two cell subpopulations.
Left: hiPSC-CM with slow (white squares) and fast (white triangles) dV/dtmax. Right: hESC-CM with slow (gray squares) and fast (gray triangles).
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